Cellebrite DI Ltd.
CLBT
$19.64
$0.080.41%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -81.10M | -59.38M | |
| Total Depreciation and Amortization | -- | -- | 10.01M | 10.41M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | 134.63M | 105.82M | |
| Change in Net Operating Assets | -- | -- | 38.52M | 37.12M | |
| Cash from Operations | -- | -- | 102.06M | 93.97M | |
| Capital Expenditure | -- | -- | -5.23M | -4.36M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -17.31M | -58.78M | |
| Cash from Investing | -- | -- | -22.54M | -63.14M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | 21.77M | 19.22M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -- | 21.77M | 19.22M | |
| Foreign Exchange rate Adjustments | -- | -- | 589.00K | 2.45M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | 101.87M | 52.50M | |